
Cerata Pharmaceuticals LLP
About Cerata Pharmaceuticals LLP
Data last updated:
Cerata Pharmaceuticals LLP is a limited liability partnership (LLP) based in Surat, Gujarat, India, recognised as a startup by DPIIT. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 11 August 2022.
The LLP is registered with the Registrar of Companies (ROC), Ahmedabad, under LLPIN ABC-0539. Its GSTIN is 24AARFC8670K1ZU (Gujarat).
The LLP has a total obligation of contribution of βΉ1 Lakh. It is led by designated partners Darshanbhai Mohanbhai Khimani and Pratik Dhirubhai Kansara.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Surat, Gujarat.
As per the financials filed for FY 2023, the LLP reported a revenue of βΉ6.23 Lakh.
The LLP is associated with 1 brand: Cerata Pharma.
Company details
Recognitions & Rankings of Cerata Pharmaceuticals
Contact details
Cerata Pharmaceuticals LLP's registered office is in Surat, Gujarat.
- Registered AddressUp Gr. Floor Shop β 2 Shivam Complex, Opp. Vaidraj Mahadev Overa A. K. Road, Surat, Gujarat, India β 395008
- IndustryPharma, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Cerata Pharmaceuticals operates one associated brand: Cerata Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Specializes in contract manufacturing of active pharmaceutical ingredients for clients. | ceratapharma.com |
Financials of Cerata Pharmaceuticals LLP
FY 2025 filings availableCerata Pharmaceuticals LLP reported revenue of βΉ6.23 Lakh for FY 2023.
Financial Statement Summary
| Statement of Account and Solvency | FY 2022-23 |
|---|---|
| Income and Expenditure | |
| Turnover | |
| Other Income | |
| Total Income | |
| Purchases and Direct Costs | |
| Personnel Expenses | |
| Administrative Expenses | |
| Interest | |
| Depreciation | |
| Total Expenses | |
| Profit Before Tax | |
| Tax | |
| Profit After Tax | |
| Profit Transferred to Partners | |
| Assets and Liabilities | |
| Partners' Contribution | |
| Reserves and Surplus | |
| Secured Loans | |
| Unsecured Loans | |
| Trade Payables | |
| Other Liabilities and Provisions | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Loans and Advances | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Statement of Account and Solvency | FY 2022-23 |
|---|---|
| Profitability | |
| Net Profit Margin | |
| Return on Partners' Funds | |
| Return on Assets | |
| Liquidity and Debt | |
| Current Ratio | |
| Debt to Partners' Funds | |
| Interest Coverage | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Turnover Growth | |
| Profit Growth | |
To see the full financial statements and ratios of Cerata Pharmaceuticals LLP, buy the company report.
Designated partners of Cerata Pharmaceuticals LLP
Cerata Pharmaceuticals has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Darshanbhai Mohanbhai Khimani Also directs: Cerata Biotech LLP | Designated Partner | 11 Aug 2022 | 4 Years 2 Months | Current |
| Pratik Dhirubhai Kansara Also directs: Cerata Biotech LLP | Designated Partner | 11 Aug 2022 | 4 Years 2 Months | Current |
Peer comparison
Cerata Pharmaceuticals LLP is compared with the 10 companies closest to it by revenue in the Pharma industry (API Manufacturers, Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| HML Pharmaceuticals Private Limited | ₹6.26 Lakh (FY 2018) | -91.0% | New Delhi, Delhi, India | |||
| K.R.R. Drugs & Intermediates Private Limited | ₹6.26 Lakh (FY 2025) | -99.0% | Ameerpet, Hyderabad, Andhra Pradesh, India | |||
| Rybult Pharmaceuticals Private Limited | ₹6.25 Lakh (FY 2023) | Panchkula, Haryana, India | ||||
| Samaksh Pharmaceuticals Private Limited | ₹6.24 Lakh (FY 2025) | -30.0% | Dlf Ph, Haryana, India | |||
| Sunflo Pharmaceuticals Private Limited | ₹6.24 Lakh (FY 2018) | -53.0% | Kalyan, Maharashtra, India | |||
| Cerata Pharmaceuticals LLP this company | ₹6.23 Lakh (FY 2023) | Surat, Gujarat, India | ||||
| Medicean Pharmaceuticals Private Limited | ₹6.23 Lakh (FY 2025) | 19.0% | Lucknow, Uttar Pradesh, India | |||
| Medidon Pharmaceuticals Private Limited | ₹6.22 Lakh (FY 2024) | -16.0% | Patna, Bihar, India | |||
| Udvell Pharmaceuticals Private Limited | ₹6.22 Lakh (FY 2022) | 210.0% | Tehri Garwal, Uttarakhand, India | |||
| Adomed Pharmaceuticals Private Limited | ₹6.21 Lakh (FY 2025) | -4.0% | Patna, Bihar, India | |||
| Rockvet Pharmaceuticals Private Limited | ₹6.2 Lakh (FY 2024) | 146.0% | Faridabad, Haryana, India |
To see the full peer comparison of Cerata Pharmaceuticals LLP, buy the company report.
Legal cases
No court or tribunal cases involving Cerata Pharmaceuticals LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cerata Pharmaceuticals LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Cerata Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AARFC8670K1ZU | Gujarat | Active | 22 Aug 2022 |
To see the full GST registrations and return filing status of Cerata Pharmaceuticals LLP, buy the company report.
Recent activity
Cerata Pharmaceuticals LLP has 2 designated partner changes on record since 2022: 2 appointments. The latest: Darshanbhai Mohanbhai Khimani was appointed as Designated Partner on 11 Aug 2022.
Frequently asked questions
Cerata Pharmaceuticals is an active limited liability partnership based in Surat, Gujarat, India. The LLP works in api manufacturers, within the pharma industry. It was incorporated on 11 August 2022 (4+ years old) and is registered under LLPIN ABC-0539.
Cerata Pharmaceuticals has 2 current designated partners:
- Darshanbhai Mohanbhai Khimani - Designated Partner
- Pratik Dhirubhai Kansara - Designated Partner
The latest financial statements of Cerata Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Cerata Pharmaceuticals is 24AARFC8670K1ZU, registered in Gujarat.
The LLPIN (Limited Liability Partnership Identification Number) of Cerata Pharmaceuticals is ABC-0539. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Cerata Pharmaceuticals was incorporated on 11 August 2022, making it 4+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Cerata Pharmaceuticals by revenue are HML Pharmaceuticals Private Limited, K.R.R. Drugs & Intermediates Private Limited, Rybult Pharmaceuticals Private Limited, Samaksh Pharmaceuticals Private Limited, Sunflo Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (API Manufacturers, Pharmaceuticals).
Darshanbhai Mohanbhai Khimani was appointed as Designated Partner on 11 Aug 2022. Pratik Dhirubhai Kansara was appointed as Designated Partner on 11 Aug 2022.
Yes, Cerata Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Cerata Pharmaceuticals is at Up Gr. Floor Shop β 2 Shivam Complex, Opp. Vaidraj Mahadev Overa A. K. Road, Surat, Gujarat, India β 395008.
Cerata Pharmaceuticals operates in the pharma industry, in the api manufacturers segment.